文献

J-GLOBAL ID：201702232373130932   整理番号：17A1146073

R-CHOP治療びまん性大細胞型B細胞リンパ腫の高齢患者の転帰: DSHNHL RICOVER-60試験と分子特性複合解析を伴うUK NCRI R-CHOP14v21試験結果

Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial

著者 (28件)： KUEHNL A. (Royal Marsden NHS Foundation Trust) ,  CUNNINGHAM D. (Royal Marsden NHS Foundation Trust) ,  COUNSELL N. (UCL Cancer Inst., London, GBR) ,  HAWKES E. A. (Royal Marsden NHS Foundation Trust) ,  HAWKES E. A. (Olivia-Newton John Cancer Res. & Wellness Centre, Melbourne, AUS) ,  QIAN W. (Cambridge Univ. Hospitals NHS Foundation Trust, Cambridge) ,  SMITH P. (UCL Cancer Inst., London, GBR) ,  CHADWICK N. (UCL Cancer Inst., London, GBR) ,  LAWRIE A. (UCL Cancer Inst., London, GBR) ,  MOUNCEY P. (UCL Cancer Inst., London, GBR) ,  JACK A. (St James’s Inst. of Oncology, Leeds) ,  POCOCK C. (East Kent Hospitals, Canterbury) ,  ARDESHNA K. M. (Univ. Coll. London, London) ,  ARDESHNA K. M. (Mount Vernon Cancer Centre, Northwood) ,  RADFORD J. (Univ. Manchester, Manchester) ,  MCMILLAN A. (Nottingham City Hospital, Nottingham) ,  DAVIES J. (Western General Hospital, Edinburgh) ,  TURNER D. (Torbay Hospital, Torquay) ,  KRUGER A. (Royal Cornwall Hospital, Truro) ,  JOHNSON P. W. (Univ. Southampton, Southampton, GBR) ,  GAMBELL J. (UCL Cancer Inst., London, GBR) ,  ROSENWALD A. (Wuerzburg Univ., Wuerzburg) ,  OTT G. (Robert-Bosch-Krankenhaus, Stuttgart) ,  HORN H. (Dr. Margarete Fischer-Bosch Inst. of Clinical Pharmacology, Stuttgart) ,  HORN H. (Univ. Tuebingen, Stuttgart) ,  ZIEPERT M. (Univ. Leipzig, Leipzig) ,  PFREUNDSCHUH M. (Saarland Univ. Medical School, Homburg/Saar, DEU) ,  LINCH D. (Univ. Coll. London, London)
資料名： Annals of Oncology  (Annals of Oncology)
巻： 28  号： 7  ページ： 1540-1546  発行年： 2017年07月 
JST資料番号： W0107A  ISSN： 0923-7534  CODEN： ANONE2  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： イギリス (GBR)  言語： 英語 (EN)

抄録/ポイント： 英国癌研究機構の60歳以上のびまん性大細胞型B細胞リンパ腫患...

シソーラス用語： *CHOP療法 ,...
準シソーラス用語： *R-CHOP ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1146073&from=J-GLOBAL&jstjournalNo=W0107A") }}

分類 (3件)： 抗腫よう薬の臨床への応用  (GW16020L) ,  血液の腫よう  (GK04000M) ,  腫ようの薬物療法  (GE03032C)

引用文献 (12件)：

• Pfreundschuh M et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 2008; 9: 105-116.
• Delarue R et al. Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial. Lancet Oncol 2013; 14: 525-533.
• Cunningham D et al. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles. Lancet 2013; 381: 1817-1826.
• Advani RH et al. Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793). Br J Haematol 2010; 151: 143-151.
• Prochazka V et al. A new prognostic score for elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: the prognostic role of blood monocyte and lymphocyte counts is absent. PLoS One 2014; 9: e102594.

タイトルに関連する用語 (7件)： R-CHOP ,  治療 ,  びまん性大細胞型B細胞リンパ腫 ,  患者の転帰 ,  試験 ,  分子特性 ,  解析